Ocular melanoma consists of posterior uveal melanoma, iris melanoma and conjunctival melanoma. These malignancies derive from melanocytes in the uveal tract or conjunctiva. The genetic profiles of these different entities differ from each other. In uveal melanoma, GNAQ and GNA11 gene mutations are frequently found and prognosis is based on mutation status of BAP1, SF3B1 and EIF1AX genes. Iris melanoma, also originating from the uvea, has similarities to the genetic makeups of both posterior uveal melanoma (UM) and conjunctival melanoma since mutations in GNAQ and GNA11 are less common and genes involved in conjunctival melanoma such as BRAF have been described. The genetic spectrum of conjunctival melanoma, however, includes frequent mutations in the BRAF, NRAS and TERT promoter genes, which are found in cutaneous melanoma as well. The BRAF status of the tumor is not correlated to prognosis, whereas the TERT promoter gene mutations are. Clinical presentation, histopathological characteristics and copy number alterations are associated with survival in ocular melanoma. Tissue material is needed to classify ocular melanoma in the different subgroups, which creates a need for the use of noninvasive techniques to prognosticate patients who underwent eye preserving treatment.

Conjunctival melanoma, Genetics, Iris melanoma, Noninvasive testing, Ocular melanoma, Uveal melanoma
dx.doi.org/10.3390/ijms22010336, hdl.handle.net/1765/133192
International Journal of Molecular Sciences
Department of Ophthalmology

van Poppelen, N.M. (Natasha M.), de Bruyn, D.P. (Daniël P.), Bicer, T. (Tolga), Verdijk, R.M, Naus, N.C, Mensink, H.W, … Kiliҫ, E. (Emine). (2021). Genetics of ocular melanoma: Insights into genetics, inheritance and testing. International Journal of Molecular Sciences (Vol. 22, pp. 1–19). doi:10.3390/ijms22010336